RSS Feeds
Zidovudine in Patients with HIV Infection
- John P.A. Ioannidis, MD;
- Joseph Lau, MD; and
- Henry S. Sacks, PhD, MD
- New England Medical Center; Boston, MA 02111 Mount Sinai Medical Center; New York, NY 10029
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
IN RESPONSE:
The risk ratio reported by Bucher and Griffith for progression to AIDS or death in long-term trials is identical to that which we obtained in our paper [1] (0.96 [CI, 0.81 to 1.13]; 0.88 [CI, 0.73 to 1.08]) if deaths …
This 100-word excerpt has been provided in the absence of an abstract.
